Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD)
作者： Walter J Lukiw
DOI: 10.1517/14728214.2012.672559
关键词:
摘要: … Because metal ion catalyzed oxidative stress and inflammatory signaling precede the appearance of aggregated Aβ peptides and SP early on in the AD process, combined or …
informahealthcare.com参考文章(158)
Richard A. Armstrong, Plaques and tangles and the pathogenesis of Alzheimer’s disease Folia Neuropathologica. ,vol. 44, pp. 1- 11 ,(2006)
M.M. Esiri, S.A. Chance, Vulnerability to Alzheimer's pathology in neocortex: The roles of plasticity and columnar organization Journal of Alzheimer's Disease. ,vol. 9, pp. 79- 89 ,(2006) , 10.3233/JAD-2006-9S310
Katsuhiko Yanagisawa, [Newly approved drugs for Alzheimer disease: effectiveness and limitation]. Brain and nerve. ,vol. 63, pp. 863- 868 ,(2011)
Itil Tm, Kunitz A, Ahmed I, Eralp E, Itil Kz, THE PHARMACOLOGICAL EFFECTS OF GINKGO BILOBA, A PLANT EXTRACT, ON THE BRAIN OF DEMENTIA PATIENTS IN COMPARISON WITH TACRINE Psychopharmacology Bulletin. ,vol. 34, pp. 391- 397 ,(1998)
Elena Tremoli, Uliano Guerrini, Paolo Gelosa, Alice Pignieri, Mauro Cimino, Luigi Sironi, The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vascular Health and Risk Management. ,vol. 3, pp. 567- 577 ,(2007)
Adnan Tanovic, Vicente Alfaro, Neuroprotección con memantina (antagonista no competitivo del receptor NMDA-glutamato) frente a la excitotoxicidad asociada al glutamato en la enfermedad de Alzheimer y en la demencia vascular Revista De Neurologia. ,vol. 42, pp. 607- 616 ,(2006) , 10.33588/RN.4210.2005252
Christiane Reitz, Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. Journal of Alzheimer's Disease. ,vol. 30, ,(2012) , 10.3233/JAD-2011-110599
Daria Orszulak-Michalak, Magdalena Jasińska, Jacek Owczarek, Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacological Reports. ,vol. 59, pp. 483- 499 ,(2007)
I. Bezprozvanny, The rise and fall of Dimebon Drug News & Perspectives. ,vol. 23, pp. 518- 523 ,(2010) , 10.1358/DNP.2010.23.8.1500435
Nathan Herrmann, Sarah A. Chau, Ida Kircanski, Krista L. Lanctôt, Current and emerging drug treatment options for Alzheimer's disease: a systematic review. Drugs. ,vol. 71, pp. 2031- 2065 ,(2011) , 10.2165/11595870-000000000-00000